Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 436 AL 450

Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices

Wang H, Shen Y, Chuang H, Chiu C, Ye Y, Zhao L.

Curr Alzheimer Res. 2019;16(7):659-674. doi: 10.2174/1567205016666190503151648.

Astroglia in Alzheimer's Disease

Verkhratsky A, Parpura V, Rodriguez-Arellano JJ, Zorec R.

Adv Exp Med Biol. 2019;1175:273-324. doi: 10.1007/978-981-13-9913-8_11.

Oligodendroglial Cells in Alzheimer's Disease

Butt AM, De La Rocha IC, Rivera A.

Adv Exp Med Biol. 2019;1175:325-333. doi: 10.1007/978-981-13-9913-8_12.

Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease

Atkinson-Dell R, Mohamet L.

Adv Exp Med Biol. 2019;1175:383-405. doi: 10.1007/978-981-13-9913-8_15.

Critical evaluation of current Alzheimer's drug discovery (2018-19) & futuristic Alzheimer drug model approach

Dorababu A.

Bioorg Chem. 2019 Dec;93:103299. doi: 10.1016/j.bioorg.2019.103299. Epub 2019 Sep 19.

[Genetic Background for Alzheimer's Disease: Knowledge Accumulated from AD GWAS]

Ozaki K, Niida S.

Brain Nerve. 2019 Oct;71(10):1039-1051. doi: 10.11477/mf.1416201403.

[Genetic Analysis of Alzheimer's Disease: The Impact of Rare Variants and Their Significance]

Miyashita A, Liu L, Hara N.

Brain Nerve. 2019 Oct;71(10):1071-1079. doi: 10.11477/mf.1416201406.

Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning

Kabir MT, Uddin MS, Begum MM, Thangapandiyan S, Rahman MS, Aleya L, Mathew B, Ahmed M, Barreto GE, Ashraf GM.

Curr Pharm Des. 2019;25(33):3519-3535. doi: 10.2174/1381612825666191008103141.

Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer's Disease

Kang DE, Woo JA.

J Alzheimers Dis. 2019;72(s1):S131-S144. doi: 10.3233/JAD-190585.

Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease

Morsy A, Trippier PC.

J Alzheimers Dis. 2019;72(s1):S145-S176. doi: 10.3233/JAD-190744.

Progressive Circuit Changes during Learning and Disease

Barth AL, Ray A.

Neuron. 2019 Oct 9;104(1):37-46. doi: 10.1016/j.neuron.2019.09.032.

Poor Diet, Stress, and Inactivity Converge to Form a "Perfect Storm" That Drives Alzheimer's Disease Pathogenesis

Pacholko AG, Wotton CA, Bekar LK.

Neurodegener Dis. 2019;19(2):60-77. doi: 10.1159/000503451. Epub 2019 Oct 10.

Current anti-Alzheimer's disease effect of natural products and their principal targets

Zhu Y, Peng L, Hu J, Chen Y, Chen F.

J Integr Neurosci. 2019 Sep 30;18(3):327-339. doi: 10.31083/j.jin.2019.03.1105.

NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy

Kabir MT, Sufian MA, Uddin MS, Begum MM, Akhter S, Islam A, Mathew B, Islam MS, Amran MS, Md Ashraf G.

Curr Pharm Des. 2019;25(33):3506-3518. doi: 10.2174/1381612825666191011102444.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias